Novel Combination Immunotherapy Improves Survival in Patients with Colorectal Cancer

Colorectal cancer is the third most common cancer worldwide. It is estimated that there are over 1.5 million diagnoses a year. Specifically, in the United States, there is estimated to have over 100,00 new…

Continue Reading


News Source: www.labroots.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *